Abstract
Elastase is a general term that has traditionally described a group of proteinases that have the ability to degrade elastin, the primary extracellular matrix (ECM) protein that confers elastic qualities to a variety of tissues, including the lungs, skin and blood vessels. Different proteinases from the serine, cysteine and metallo classes have been shown to degrade elastin with varying degrees of activity. Of these different classes of proteinases, other than the metalloproteinase metalloelastase [matrix metalloprotein 12 (MMP-12) (SHAPIRO 1994; GRONSKI et al. 1997; MECHAM et al. 1997)], the serine elastases — pancreatic elastase (PE), neutrophil elastase (NE), proteinase-3 (PR-3) — have been the subject of the most intensive investigations thus far. These three enzymes have been characterized extensively, and their crystal structures have been elucidated and published. Two additional enzymes [endogenous vascular elastase (EVE) and endothelial cell elastase (ECE)] are, as yet, less well characterized and have only been identified as having “elastase-like” activities based on substrate and inhibitor activity profiles, although EVE has been shown to degrade insoluble elastin (BUSSOLINO et al. 1994; ZHU et al. 1994). Finally, at least three other serine elastases, as defined by their substrate/inhibition profiles, have been described; these were derived from transformed rat- liver epithelial or Schwann cells, human carcinoma cell lines (CAPPELLUTI and HARRIS 1994), human skin fibroblasts (CROUTE et al. 1991) and human lymphocytes (PACKARD et al. 1995). The relationships of these enzymes to PE, NE, PR-3, EVE and ECE are not known. This review will focus on NE, PR-3, EVE and, to a lesser extent, ECE, with respect to their potential roles in inflammatory and vascular diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Baugh RJ, Travis J (1976) Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 15:836–841
Bergenfeldt M, Axelsson L, Ohlsson K (1992) Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 52:823–829
Bories D, Raynal MC, Solomon DH, Darzynkiewicz Z, Cayre YE (1989) Downregulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 59:959–968
Boudreau N, Turley E, Rabinovitch M (1991) Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev Biol 143:235–247
Bussolino F, Arese M, Silvestro L, Soldi R, Benfenati E, Sanavio F, Aglietta M, Bosia A, Camussi G (1994) Involvement of a serine protease in the synthesis of plateletactivating factor by endothelial cells stimulated by tumor necrosis factor-α or interleukin-1α. Eur J Immunol 24:3131–3139
Campanelli D, Melchior M, Fu Y, Nakata M, Shuman H, Nathan C, Gabay JE (1990) Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 172:1709–1715
Campbell EJ, Senior RM, McDonald JA, Cox DL (1982) Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest 70:845–852
Campbell EJ, Silverman EK, Campbell MA (1989) Elastase and cathepsin G of human monocytes. J Immunol 143:2961–2968
Cappelluti E, Harris RB (1994) Proteolytic maturation of transforming growth factor-α. Perspect Drug Discov Design 2:353–361
Coeshott C, et al. (1999) Converting enzyme-independent release of TNFα and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA (in press)
Cowan B, Baron O, Crack J, Coulber C, Wilson GJ, Rabinovitch M (1996) Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits following heterotopic cardiac transplantation. J Clin Invest 97:2452–2468
Croute F, Delaporte E, Bonnefoy JY, Fertin C, Thivolet J, Nicolas JF (1991) Interleukin-1β stimulates fibroblast elastase activity. Br J Dermatol 124:538–541
Csernok E, Ludemann J, Gross WL, Bainton DF (1990) Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener’s granulomatosis. Am J Pathol 137:1113–1120
Csernok E, et al. (1991) Translocation of proteinase 3 on the cell surface of neutrophils: association with disease activity in Wegener’s granulomatosis (abstract). Arthritis Rheum 34[Suppl 9]:571
Dalet-Fumeron V, Guinec N, Pagano M (1993) In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinasetype plasminogen activator. FEBS Lett 332:251–254
Del Mar EG, Largman C, Brodrick JW, Fassett M, Geokas MC (1980) Substrate specificity of human pancreatic elastase 2. Biochemistry 19:468–472
Delclaux C, Delacourt C, D’Ortho MP, Boyer V, Lafuma C, Harf A (1996) Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 14:288–295
Edelstein C, Italia JA, Scanu AM (1997) Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. J Biol Chem 272:11079–11087
Fantuzzi G, Ku G, Harding MW, Livingston DJ, Sipe JD, Kuida K, Flavell RA, Dinarello CA (1997) Response to local inflammation of IL-1α-converting enzyme-deficient mice. J Immunol 158:1818–1824
Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC (1997) Activation MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 402:111–115
Galis ZS, Kranzhofer R, Fenton JW II, Libby P (1997) Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:483–489
Gronski TJ Jr, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD (1997) Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 272:12189–12194
Heck LW, Blackburn WD, Irwin MH, Abrahamson DR (1990) Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am J Pathol 136:1267–1274
Henshaw TJ, Malone CC, Gabay JE, Williams RC Jr (1994) Elevations of neutrophil proteinase 3 in serum of patients with Wegener’s granulomatosis and polyarteritis nodosa. Arthritis Rheum 37:104–112
Itoh Y, Nagase H (1995) Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (proge-latinase B) by human neutrophil elastase. J Biol Chem 270:16518–16521
Janoff A (1973) Purification of human granulocyte elastase by affinity chromatography. Lab Invest 29:458–464
Janoff A, Scherer J (1968) Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med 128:1137–1155
Jennette JC, Hoidal JR, Falk RJ (1990) Correspondence: specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75:2263–2264
Jones PL, Rabinovitch M (1996) Tenascin-C is induced with progressive pulmonary vascular disease in rats is functionally related to increased smooth muscle cell proliferation. Circ Res 79:1131–1142
Jones PL, Cowan KN, Rabinovitch M (1997a)Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 150:1349–1360
Jones PL, Crack J, Rabinovitch M (1997b) Regulation of Tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139:279–293
Jordan RE, Nelson RM, Kilpatrick J, Newgren JO, Esmon PC, Fournel MA (1989) Inactivation of human antithrombin by neutrophil elastase. J Biol Chem 264: 10493–10500
Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR (1988) Proteinase 3: a distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 82:1963–1973
Klebanoff SJ, Kinsella MG, Wight TN (1993) Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system. Am J Pathol 143:907–917
Kleniewski J, Donaldson V (1988) Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity. J Exp Med 167: 1895–1907
Kobayashi J, Wigle D, Childs T, Zhu L, Keeley FW, Rabinovitch M (1994) Seruminduced vascular smooth muscle cell elastolytic activity through tyrosine kinase intracellular signalling. J Cell Physiol 160:121–131
Koppel R, Han RN, Cox D, Tanswell AK, Rabinovitch M (1994) a1-Antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity. Pediatr Res 36:763–770
Lee J-K, et al. (1997) Elastase inhibitor reduces sequelae of experimental murine myocarditis. Circulation 96:738
Lewis RW, Harwood JL, Tetley TD, Harris E, Richards RJ (1993) Degradation of human and rat surfactant apoprotein by neutrophil elastase and cathepsin G. Biochem Soc Trans 21:206S
Liau DF, Yin NX, Huang J, Ryan SF (1996) Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro. Biochim Biophys Acta 1302:117–128
Maruyama K, Ye CL, Woo M, Venkatacharya H, Lines LD, Silver MM, Rabinovitch M (1991) Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am J Physiol 261:H1716–H1726
McDonald JA, Kelley DG (1980) Degradation of fibronectin by human leukocyte elastase. J Biol Chem 255:8848–8858
McGowan SE (1990) Mechanisms of extracellular matrix proteoglycan degradation by human neutrophils. Am J Respir Cell Mol Biol 2:271–279
McRae B, Nakajima K, Travis J, Powers JC (1980) Studies on reactivity of human leukocyte elastase, cathepsin G, and porcine pancreatic elastase toward peptides including sequences related to the reactive site of α1protease inhibitor (α1antitrypsin). Biochemistry 19:3973–3978
Mecham RP, Broekelmann TJ, Fliszar CJ, Shapiro SD, Welgus HG, Senior RM (1997) Elastin degradation by matrix metalloproteinases. J Biol Chem 272:18071–18076
Mehta JL, Nichols WW, Nicolini FA, Hendricks J, Donnelly WH, Saldeen TG (1994) Neutrophil elastase inhibitor ICI 200,880 protects against attenuation of coronary flow reserve and myocardial dysfunction following temporary coronary artery occlusion in the dog. Cardiovasc Res 28:947–956
Mueller SG, Paterson AJ, Kudlow JE (1990) Transforming growth factor α in arterioles: cell surface processing of its precursor by elastases. Mol Cell Biol 10:4596–4602
Murohara T, Guo JP, Lefer AM (1995) Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury. J Pharmacol Exp Ther 274:1246–1253
Nakajima K, Powers JC, Ashe BM, Zimmerman M (1979) Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. J Biol Chem 254:4027–4032
Nakano M, et al. (1995) Preventive effects of ulinastatin for coronary artery aneurysm formation in Kawasaki disease. Elsevier Science BV, Amsterdam, pp 364–371
O’Blenes S, et al. Gene transfer with elafin reduces neointimal formation and promotes adventitial remodeling in vein grafts. Circulation (in press)
Oho S, Rabinovitch M (1994) Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. Am J Pathol 145:202–210
Okada Y, Watanabe S, Nakanishi I, Kishi J, Hayakawa T, Watorek W, Travis J, Nagase H (1988) Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 229:157–160
Owen CA, Campbell EJ (1995) Neutrophil proteinases and matrix degradation. The cell biology of pericellular proteolysis. J Cell Biol 6:367–376
Packard BZ, Mostowski HS, Komoriya A (1995) Mitogenic stimulation of human lymphocytes mediated by a cell surface elastase. Biochim Biophys Acta 1269: 51–56
Padrines M, Wolf M, Walz A, Baggiolini M (1994) Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett 352:231–235
Pison U, Tam EK, Caughey GH, Hawgood S (1989) Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 992:251–257
Rabinovitch M, Bothwell T, Hayakawa BN, Williams WG,Trusler GA, Rowe RD, Olley PM, Cutz E (1986) Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension: a correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest 55:632–653
Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR (1991) Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. J Biol Chem 266:9540–9548
Rice A, Banda MJ (1995) Neutrophil elastase processing gelatinase A is mediated by extracellular matrix. Biochemistry 34:9249–9256
Robache-Gallea S, Morand V, Bruneau JM, Schoot B, Tagat E, Realo E, Chouaib S, Roman-Roman S (1995) In vitro processing of human tumor necrosis factor-α. J Biol Chem 270:23688–23692
Sandhaus RA, Werb Z (1981) Characterization of the major form of elastase in neutrophil granules. Fed Proc 40:1004
Schwartz L, Blew B, Bui S (1997) Intracoronary-stent placement for coronary artery disease. Lancet 350:113–114
Shapiro SD (1994) Elastolytic metalloproteinases produced by human mononuclear phagocytes. Am J Respir Crit Care Med 150:S160-S164
Si-Tahar M, Pidard D, Balloy V, Moniatte M, Kieffer N, Van Dorsselaer A, Chignard M (1997) Human neutrophil elastase proteolytically activates the platelet integrin α11bβ3 through cleavage of the carboxyl terminus of the α11b subunit heavy chain. J Biol Chem 272:11636–11647
Starkey PM (1997)Elastase and cathepsin G; the serine proteinases of human neutrophil leucocytes and spleen, proteinases in mammalian cells and tissues. North-Holland, Amsterdam, pp 57–58
Stiskal JA, Dunn MS, Shennan AT, O’Brien KKE, Kelly EN, Koppel RI, Cox DW, Ito S, Chappel SL, Rabinovitch M (1998) Alphal-proteinase inhibitor therapy for the prevention of bronchopulmonary dysplasia in premature infants: a randomized controlled trial. Pediatrics 101:89–94
Thompson K, Rabinovitch M (1996) Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix-bound basic fibroblast growth factor. J Cell Physiol 166:495–505
Thompson K, Kobayashi J, Childs T, Wigle D, Rabinovitch M (1998) Endothelial and serum factors which include apolipoprotein Al tether elastin to smooth muscle cells inducing serine elastase activity via tyrosine kinase-mediated transcription and translation. J Cell Physiol 174:78–89
Todorovich-Hunter L, Dodo H, Ye C, McCready L, Keeley FW, Rabinovitch M (1992) Increased pulmonary artery elastolytic activity and monocrotaline-induced progressive hypertensive pulmonary vascular disease in adult rats compared to infant rats with non-progressive disease. Am Rev Respir Dis 146:213–223
Tosi MF, Zakem H, Berger M (1990) Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 86:300–308
Vender RL (1996) Therapeutic potential of neutrophil-elastase inhibition in pulmonary disease. J Investig Med 44:531–539
Vissers MCM, Winterbourn CC (1988) Activation of human neutrophil gelatinase by endogenous serine proteinases. Biochem J 249:327–331
Weiss SJ, Regiani S (1984) Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. J Clin Invest 73:1297–1303
Werb Z, Banda MJ, McKerrow JH, Sandhaus RA (1982) Elastases and elastase degradation. J Invest Dermatol 79(Suppl 1):154s-159s
Ye C, Rabinovitch M (1991) Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension. Am J Physiol 261:H1255–H1267
Zhu L, Wigle D, Hinek A, Kobayashi J, Ye C, Zuker M, Dodo H, Keeley FW, Rabinovitch M (1994) The endogenous vascular elastase which governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest 94:1163–1171
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cheronis, J.C., Rabinovitch, M. (2000). Serine Elastases in Inflammatory and Vascular Diseases. In: von der Helm, K., Korant, B.D., Cheronis, J.C. (eds) Proteases as Targets for Therapy. Handbook of Experimental Pharmacology, vol 140. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57092-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-57092-6_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63023-1
Online ISBN: 978-3-642-57092-6
eBook Packages: Springer Book Archive